Internal Medicine, Gastroenterology · Flushing, NY
NPI
1740233253
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
13619 41st Ave
Flushing, NY, 11355
Phone (718) 886-6330
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
65 services
Medicare patients, 2024
30
Average age 71
Drug cost, 2024
$450K
1,808 prescriptions
Company payments, 2025
$1,003
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Xianyang Yio was code 99213 (office e&m - established), 23 times for 20 patients. In total Xianyang Yio billed 65 services in 9 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-03-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 23 | 20 | $81.20 | $1,868 |
| 43239 Upper GI Endoscopy | Office | 11 | 11 | $348.20 | $3,830 |
By year: 2022 $32K for 142 services; 2023 $28K for 133 services; 2024 $12K for 65 services.
Medicare prescription drug claims, 2024
In 2024, the drug Xianyang Yio prescribed most often to Medicare patients was Famotidine, with 307 prescriptions and refills. In total Xianyang Yio wrote 1,808 Medicare prescriptions that cost $450K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 307 | 308 | 249 | $1,923 |
| Pantoprazole Sodium Generic | 289 | 291 | 231 | $1,168 |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 157 | 157 | 153 | $20K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 148 | 148 | 143 | $10K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 92 | 92 | 91 | $1,594 |
| Sucralfate Generic | 84 | 89 | 33 | $2,295 |
| Vemlidy Tenofovir Alafenamide | 80 | 80 | Under 11 | $111K |
| Linzess Linaclotide | 67 | 69 | 21 | $36K |
| Hydrocortisone Generic | 55 | 55 | 24 | $1,858 |
| Omeprazole Generic | 44 | 46 | 41 | $304 |
| Ursodiol Generic | 40 | 51 | Under 11 | $99K |
| Procto-Med Hc Hydrocortisone | 38 | 40 | 15 | $521 |
| Xifaxan Rifaximin | 36 | 36 | 26 | $85K |
| Creon Lipase/Protease/Amylase | 26 | 29 | 13 | $36K |
| Metronidazole Generic | 19 | 19 | 16 | $109 |
Brand drugs: 505 claims; generic drugs: 1,291 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Xianyang Yio $1,003 ($1,003 in general payments such as food, travel and fees) from 8 companies. The largest payer was Gilead Sciences, Inc. with $493.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 21 | $493 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 12 | $204 |
| Madrigal Pharmaceuticals MDGL | 4 | $83.93 |
| Phathom Pharmaceuticals, Inc. PHAT | 4 | $74 |
| Intra-Sana Laboratories | 2 | $50.24 |
| Abbvie Inc. ABBV | 3 | $49.08 |
| Aimmune Therapeutics, Inc. | 1 | $26.8 |
| Ardelyx, Inc. ARDX | 1 | $22.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.